Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
James C. Yao(The University of Texas MD Anderson Cancer Center), Nicola Fazio(European Institute of Oncology), Simron Singh(Sunnybrook Health Science Centre), Roberto Buzzoni(Fondazione IRCCS Istituto Nazionale dei Tumori), Carlo Carnaghi(IRCCS Humanitas Research Hospital), Edward M. Wolin(University of Kentucky), Jiří Tomášek(Masaryk Memorial Cancer Institute), Markus Raderer(Arbeitsgemeinschaft für Klinische Ernährung), Harald Lahner, Maurizio Voi(Novartis (United States)), Lida Pacaud(Novartis (Switzerland)), Nicolas Rouyrre(Novartis (Switzerland)), Carolin Sachs(Novartis (Switzerland)), Juan W. Valle(University of Manchester), Gianfranco Delle Fave(Azienda Ospedaliera Sant'Andrea), Eric Van Cutsem(KU Leuven), Margot Tesselaar(The Netherlands Cancer Institute), Yasuhiro Shimada(Tokyo National Hospital), Do‐Youn Oh(Seoul National University Hospital), Jonathan Strosberg(Moffitt Cancer Center), Matthew H. Kulke(Dana-Farber Cancer Institute), Marianne Pavel(Charité - Universitätsmedizin Berlin)
Cited by 1,256
Abstract
Related Papers
No related papers found
Powered by citation graph analysis